APA (7th ed.) Citation

Liu, D., Glubb, D., O'Mara, T., & Ford, C. E. The Multi‐Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre‐Clinical Efficacy in Endometrial Cancer. Wiley.

Chicago Style (17th ed.) Citation

Liu, Dongli, Dylan Glubb, Tracy O'Mara, and Caroline E. Ford. The Multi‐Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre‐Clinical Efficacy in Endometrial Cancer. Wiley.

MLA (9th ed.) Citation

Liu, Dongli, et al. The Multi‐Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre‐Clinical Efficacy in Endometrial Cancer. Wiley.